G-Rex Grant Tour New York -

G-Rex® Grant Tour

Supporting the Emily Whitehead Foundation

Phoenix

Arizona Science Center - 600 E. Washington St., Phoenix, AZ 85004

Wednesday, November 4, 2026
5:00PM - 9:00PM

The Phoenix G-Rex Grant Tour event is presented in partnership with

Hear from leaders bringing hope to patients through advanced cell & gene therapies

Meet Mr. Tony Busby

Tony Busby is an account manager with Legend Biotech, the manufacturer of CARVYKTI®, a CAR-T cell therapy for patients with relapsed refractory multiple myeloma. His career has been shaped by a lifelong commitment to improving patient outcomes and expanding access to innovative therapies.After spending 23 years with Novo Nordisk as a regional education manager, supporting cardiovascular, diabetes, and obesity care. Tony's professional path took a deeply personal turn in 2020 when his daughter, Breya, was diagnosed with acute lymphoblastic leukemia (ALL). Witnessing her battle with cancer and the life-saving impact of CAR-T therapy ignited a passion for advancing awareness and access to breakthrough treatments for patients facing life-threatening diseases.Following Breya's successful CAR-T treatment, Tony transitioned into oncology/hematology with Sanofi, where he focused on bone marrow transplantation (BMT) and graft-versus-host disease (GVHD), gaining valuable experience supporting patients and healthcare providers navigating complex cancer care. This work ultimately led him to Legend Biotech, where he now partners with community oncology and treatment centers to help bring innovative cell therapies to patients with multiple myeloma.Driven by both professional experience and personal purpose, Tony is passionate about helping children and adults with cancer gain access to life-saving cell and gene therapies. He is dedicated to supporting healthcare providers, educating communities, and advocating for innovations that give patients the opportunity to live longer, healthier, and more purpose-driven lives.Outside of his professional responsibilities, Tony remains committed to raising awareness about the transformative potential of cell and gene therapies and the profound difference they can make for patients and families facing serious illnesses.
Ms. Laurie Adami

Meet Ms. Laurie Adami

In 2006, Laurie was president of a Los Angeles based financial software company when at the age of 46, with a young son in kindergarten, she was diagnosed with incurable follicular non Hodgkin lymphoma, the second most common type of NHL.She spent 12 years in non stop treatment with numerous lines of therapy before getting a treatment that worked for her in 2018. She now spends her time as a volunteer patient advocate helping other patients navigate their cancer journeys. She is also writing amemoir about her journey to help others on the road behind her.
Kim Schuetz

Meet Ms. Kim Schuetz

Kim Schuetz is a seasoned oncology nurse based in Fall River, Wisconsin, with over two decades of experience in direct patient care and clinical support. In addition to her professional background, Kim is a passionate childhood cancer advocate and the mother of Austin Schuetz, the 21st pediatric patient in the world to receive CAR-T cell therapy. Their remarkable journey through treatment and recovery has been featured widely, including by the Alliance for Cancer Gene Therapy (ACGT) and the Emily Whitehead Foundation.Since connecting with the Emily Whitehead Foundation over eight years ago, Kim has been a steadfast supporter, sharing her family’s story at major events such as the Believe Ball and engaging in peer support, advocacy, and public speaking across oncology nursing, patient communities, and industry audiences. As both a nurse and caregiver, Kim brings a unique dual perspective to her advocacy, rooted in clinical insight and personal resilience. She continues to champion awareness, equitable access to advanced therapies, and patient-centered care models across the oncology space.
Austin Schuetz

Meet Mr. Austin Schuetz

Austin Schuetz was diagnosed with B-cell acute lymphoblastic leukemia shortly before his third birthday. Following multiple relapses, extensive chemotherapy, radiation, and a bone marrow transplant, his family was told that few treatment options remained. In October 2013, at age five, Austin became the 21st pediatric patient in the world to receive CAR T-cell therapy.Today, Austin is 18 years old and preparing for his senior year of high school. He works as a youth apprentice and CNC machine operator and hopes to pursue a career in the trades. Austin has shared his story through the Emily Whitehead Foundation to demonstrate the life-changing impact of innovative cancer research and advanced therapies. His experience offers a powerful reminder of what scientific progress makes possible for children and families facing difficult diagnoses.

Global Resources, Phoenix Innovation.

Join the coalition accelerating patient cures right here in Phoenix
Inspiring Patient & Caregiver Stories

Hear firsthand from cancer survivor Kim Schuetz as she shares her powerful journey of recovery alongside top industry advocates.

Breakthroughs in Solid Tumor Cancer Research

Join leading experts as they discuss new cellular immunotherapies and hope for solid tumor patients.

Innovations in Ex Vivo Cell & Gene Therapy Manufacturing

Connect with leading scientists to explore the next generation of manufacturing advancements.

Event Sponsors
Event Essentials

Prepare for a full day of innovation, networking, and impact.

G-Rex Grant Tour

If you're building the future of cell therapy - this is your place

Interested in Sponsoring?

Are you a provider of tools, technology, or services used in research, development, or manufacturing of cell and gene therapies?
Does your innovation pair nicely with G-Rex?
If yes, please consider sponsoring one, some, or all of the G-Rex Grant Tour events.  Your sponsorship is a tax deductible donation to the Emily Whitehead Foundation.